Tanios Bekaii-Saab

Tanios Bekaii-Saab is a gastrointestinal oncologist at Mayo Clinic leading clinical trials in pancreatic cancer including adjuvant and neoadjuvant strategies integrating FOLFIRINOX-based regimens and targeted agents. His work examines novel treatment combinations in resected and borderline resectable pancreatic cancer, with particular interest in KRAS-targeted approaches. He leads an active clinical trials program in PDAC and contributes to national cooperative group GI trial development. Bekaii-Saab is a recognized expert on systemic therapy selection and sequencing for pancreatic cancer across disease stages.